NCT03685110

CoreHip - Post Market Clinical Follow-Up Study

Prospective, Non-Interventional, Multicenter, Post-Market Clinical Follow-up Study CoreHip®

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 248 (actual)
• Sponsor: Aesculap AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

Detailed description

The CoreHip® System has a range of different stem designs to address most of the indications and anatomical conditions met in Primary THA patients within one implant and Instrument System.

Conditions

• Degenerative Osteoarthritis
• Rheumatic Arthritis
• Fractures, Hip
• Necrosis, Femur Head

Interventions

Type	Name	Description
DEVICE	CoreHip Total Hip Arthroplasty	Replacement of the Hip Joint

Timeline

• Start date: 2018-10-16
• Primary completion: 2023-04-30
• Completion: 2028-12-01
• First posted: 2018-09-26
• Last updated: 2026-03-31

Locations

6 sites across 2 countries: Germany, Switzerland